Emily Bongiorno

Immunology and Microbiology · Life Sciences

5h-index163citations22works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(9), Cancer Immunotherapy and Biomarkers(5), Rabies epidemiology and control(5), Glioma Diagnosis and Treatment(4), CAR-T cell therapy research(4)

Publications22 total

Table S1 from Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
2023Open Access
Data from Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
2023Open Access
Figure S1 from Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
2023Open Access
Figure S1 from Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
2023Open Access
Table S1 from Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
2023Open Access
Data from Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
2023Open Access
Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
Clinical Cancer Research·2021· 52 citedOpen Access
Is Host Metabolism the Missing Link to Improving Cancer Outcomes?
Cancers·2020· 4 citedOpen Access
Abstract B86: Treatment of glioma cells with IGF-1R antisense and irradiation induces the production of antigens that stimulate IFNγ production by tumor-specific CD4 T cells
Cancer Immunology Research·2020
Abstract CT038: Results of a Phase Ib trial of an autologous cell vaccine for newly diagnosed glioblastoma
Clinical Trials·2019· 1 cited
Abstract CT038: Results of a Phase Ib trial of an autologous cell vaccine for newly diagnosed glioblastoma
Cancer Research·2019· 1 cited
Targeting VPAC1 Receptors for Imaging Glioblastoma
Molecular Imaging and Biology·2019· 5 cited
Abstract B15: Combination immunotherapy of murine prostate cancer using a <i>Listeria</i>-based PSA vaccine: Immune correlates of efficacy and resistance development
Cancer Immunology Research·2018· 1 cited
Optimizing vaccine immunotherapy for prostate cancer
The Medicine Forum·2018Open Access
Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors
The Journal of Immunology·2017· 13 cited
Therapeutic modulation of the tumor-promoting immune type 2 microenvironment in malignant glioma by the induction of a type 1 response to attenuated rabies virus
The Medicine Forum·2016Open Access
Attenuated rabies virus promotes CNS immune infiltration and tumor necrosis in a mouse model of glioma (TUM10P.1059)
The Journal of Immunology·2015
Expression of Interferon Gamma by a Recombinant Rabies Virus Strongly Attenuates the Pathogenicity of the Virus via Induction of Type I Interferon
Journal of Virology·2014· 39 citedOpen Access
A novel rabies virus-based glioma immunotherapeutic strategy targeting survivin (P4440)
The Journal of Immunology·2013· 2 cited
Intramuscular Inoculation of Mice with the Live-Attenuated Recombinant Rabies Virus TriGAS Results in a Transient Infection of the Draining Lymph Nodes and a Robust, Long-Lasting Protective Immune Response against Rabies
Journal of Virology·2012· 36 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

D. Craig Hooper(15), Samantha Garcia(12), Rhonda Kean(12), Sami Sauma(10), David W. Andrews(9), Kevin Judy(9), Charles Scott(9), Larry A. Harshyne(9), Kiran Talekar(9), Adam E. Flanders(9), Kofi‐Buaku Atsina(9), Lyndon Kim(9), Nina Martinez(9), Wenyin Shi(9), Maria Werner‐Wasik(9), Mikhail Prosniak(9), Mark Curtis(9), Kara Pigott(9), Lawrence C. Kenyon(8), Haisong Liu(7)